Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum

Herein we investigate the structure/function relationships of fucoidans from Ascophyllum nodosum to analyze their pro-angiogenic effect and cellular uptake in native and glycosaminoglycan-free (GAG-free) human endothelial cells (HUVECs). Fucoidans are marine sulfated polysaccharides, which act as glycosaminoglycans mimetics. We hypothesized that the size and sulfation rate of fucoidans influence their ability to induce pro-angiogenic processes independently of GAGs. We collected two fractions of fucoidans, Low and Medium Molecular Weight Fucoidan (LMWF and MMWF, respectively) by size exclusion chromatography and characterized their composition (sulfate, fucose and uronic acid) by colorimetric measurement and Raman and FT-IR spectroscopy. The high affinities of fractionated fucoidans to heparin binding proteins were confirmed by Surface Plasmon Resonance. We evidenced that LMWF has a higher pro-angiogenic (2D-angiogenesis on Matrigel) and pro-migratory (Boyden chamber) potential on HUVECs, compared to MMWF. Interestingly, in a GAG-free HUVECs model, LMWF kept a pro-angiogenic potential. Finally, to evaluate the association of LMWF-induced biological effects and its cellular uptake, we analyzed by confocal microscopy the GAGs involvement in the internalization of a fluorescent LMWF. The fluorescent LMWF was mainly internalized through HUVEC clathrin-dependent endocytosis in which GAGs were partially involved. In conclusion, a better characterization of the relationships between the fucoidan structure and its pro-angiogenic potential in GAG-free endothelial cells was required to identify an adapted fucoidan to enhance vascular repair in ischemia.

[1]  Loïc Martin,et al.  Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells , 2007, Molecular Cancer Therapeutics.

[2]  Jung-Hwan Yoon,et al.  Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Paulo J. A. Ribeiro-Claro,et al.  Identification of selected seaweed polysaccharides (phycocolloids) by vibrational spectroscopy (FTIR-ATR and FT-Raman) , 2009 .

[4]  Rongying Zhang,et al.  The effect of the size of fluorescent dextran on its endocytic pathway , 2015, Cell biology international.

[5]  Didier Letourneur,et al.  Low Molecular Weight Fucoidan Increases VEGF165-induced Endothelial Cell Migration by Enhancing VEGF165 Binding to VEGFR-2 and NRP1* , 2006, Journal of Biological Chemistry.

[6]  Beom-Su Kim,et al.  Fucoidan/FGF-2 induces angiogenesis through JNK- and p38-mediated activation of AKT/MMP-2 signalling. , 2014, Biochemical and biophysical research communications.

[7]  P. Hwang,et al.  Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia , 2015, Marine drugs.

[8]  J. Michel,et al.  Low-Molecular-Weight Fucoidan Promotes Therapeutic Revascularization in a Rat Model of Critical Hindlimb Ischemia , 2003, Journal of Pharmacology and Experimental Therapeutics.

[9]  A. Amarasekara,et al.  Effect of oversulfation on the chemical and biological properties of fucoidan , 2006 .

[10]  D. Le Guludec,et al.  Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction , 2014, Marine drugs.

[11]  A. Duchesnay,et al.  Synthesis and biological activities of a library of glycosaminoglycans mimetic oligosaccharides. , 2011, Biomaterials.

[12]  E. Tkachenko,et al.  Syndecans: new kids on the signaling block. , 2005, Circulation research.

[13]  F. Chaubet,et al.  Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets. , 2009, Biochimica et biophysica acta.

[14]  U. Welsch,et al.  GLYCOCALYX PROTECTION REDUCES LEUKOCYTE ADHESION AFTER ISCHEMIA/REPERFUSION , 2010, Shock.

[15]  R. Williams,et al.  A revised structure for fucoidan may explain some of its biological activities. , 1993, The Journal of biological chemistry.

[16]  Structural Features and Anti-coagulant Activity of the Sulphated Polysaccharide SPS-CF from a Green Alga Capsosiphon fulvescens , 2015, Marine Biotechnology.

[17]  Shingo Nakamura,et al.  Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization. , 2008, Journal of biomedical materials research. Part A.

[18]  P. Albanese,et al.  A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: towards a matrix-based therapy? , 2015, European cells & materials.

[19]  Menger,et al.  The polysaccharide fucoidan inhibits microvascular thrombus formation independently from P‐ and l‐selectin function in vivo , 2000, European journal of clinical investigation.

[20]  M. Bilan,et al.  Structure of a fucoidan from the brown seaweed Fucus evanescens C.Ag. , 2002, Carbohydrate research.

[21]  V. Pomin.  Fucanomics and galactanomics: current status in drug discovery, mechanisms of action and role of the well-defined structures. , 2012, Biochimica et biophysica acta.

[22]  Diego Mantovani,et al.  Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice , 2013, Drug Delivery and Translational Research.

[23]  Rangeetha J Naik,et al.  Exogenous chondroitin sulfate glycosaminoglycan associate with arginine-rich peptide-DNA complexes to alter their intracellular processing and gene delivery efficiency. , 2015, Biochimica et biophysica acta.

[24]  G. Garcı́a-Cardeña,et al.  Hemodynamic shear stress characteristic of atherosclerosis-resistant regions promotes glycocalyx formation in cultured endothelial cells. , 2013, American journal of physiology. Cell physiology.

[25]  A. Sutton,et al.  Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells. , 2009, Glycobiology.

[26]  Xiang-yang Zou,et al.  Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma , 2015, Marine drugs.

[27]  A. Sutton,et al.  Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis , 2015, Marine drugs.

[28]  M. Bilan,et al.  Fucoidans: pro- or antiangiogenic agents? , 2014, Glycobiology.

[29]  S. Matou,et al.  Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro. , 2002, Thrombosis research.

[30]  O. Berteau,et al.  Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. , 2003, Glycobiology.

[31]  J. Turnbull,et al.  A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis , 2005, Journal of Cell Science.

[32]  G. Caligiuri,et al.  Neoangiogenesis induced by progenitor endothelial cells: effect of fucoidan from marine algae. , 2007, Cardiovascular & hematological agents in medicinal chemistry.

[33]  J. Deux,et al.  Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia in Rabbit Iliac Artery In-Stent Restenosis Model , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[34]  M. Bilan,et al.  Influence of Fucoidans on Hemostatic System , 2013, Marine drugs.

[35]  Maeve Kelly,et al.  A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. , 2007, Glycobiology.

[36]  Sylvie Ricard-Blum,et al.  Heparin-protein interactions: from affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[37]  Soraya Fermas,et al.  Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis. , 2008, Glycobiology.

[38]  A. Sutton,et al.  Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression. , 2011, Biochemical pharmacology.

[39]  B. Caleb,et al.  Binding and internalization of heparin by vascular smooth muscle cells , 1985, Journal of cellular physiology.

[40]  P. Legrand,et al.  A spectroscopic investigation of the carrageenans and agar in the 1500-100 cm−1 spectral range , 1993 .